Gastroenterology clinical trials recruiting in Texas

99 recruiting gastroenterology trials match in Texas. Showing 20.

• LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Fort Worth, Texas

• Study of XmAb942 in Healthy Participants and Participants With Ulcerative ColitisRecruiting

  Phase 1 / Phase 2 · Xencor, Inc. · Cedar Park, Texas

• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisRecruiting

  Phase 2 · Sanofi · Katy, Texas

• Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentRecruiting

  N/A · Fresenius Kabi · Houston, Texas

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting

  Phase 3 · Boehringer Ingelheim · Arlington, Texas

• Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASHRecruiting

  Phase 2 · Madrigal Pharmaceuticals, Inc. · Dallas, Texas

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Hoffmann-La Roche · Dallas, Texas

• Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruiting

  Phase 2 · AbbVie · Cedar Park, Texas

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Austin, Texas

• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisRecruiting

  Phase 2 · Spyre Therapeutics, Inc. · Cedar Park, Texas

• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative ColitisRecruiting

  Phase 2 · Sanofi · Houston, Texas

• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Sanofi · Baytown, Texas

• Confirmatory Clinical Study in Active Ulcerative ColitisRecruiting

  Phase 2 · MRM Health NV · San Antonio, Texas

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Bellaire, Texas

• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative ColitisRecruiting

  Phase 2 / Phase 3 · Bristol-Myers Squibb · Houston, Texas

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 3 · Hoffmann-La Roche · Galveston, Texas

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisRecruiting

  Phase 2 · Eli Lilly and Company · Baytown, Texas

• A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's DiseaseRecruiting

  Phase 2 · Sanofi · Fredericksburg, Texas

• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)Recruiting

  Phase 4 · Takeda · Dallas, Texas

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Corsicana, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.